Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Total revenues	$ 89,463	$ 66,517	$ 77,794
Total costs and expenses	(85,174)	(68,508)	(70,070)
Gross profit	4,289	(1,991)	7,724
Income from operating investments, net	25	71	46
General and administrative expense	(6,090)	(5,021)	(5,168)
Research and development expense, net	(3,615)	(3,812)	(3,377)
Gain on dispositions, net	(9,672)	(46)	(2)
Earnings/(loss) from operations	4,281	(10,707)	(773)
Other income, net	1,125	1,222	1,227
Interest and debt expense	(2,771)	(2,725)	(2,459)
Earnings/(loss) before income taxes	2,635	(12,210)	(2,005)
Income tax (expense)/benefit	(397)	381	(237)
Net earnings/(loss)	2,238	(11,829)	(2,242)
Less: Net earnings/(loss) attributable to noncontrolling interest	3	(12)	(20)
Net earnings/(loss) attributable to Boeing shareholders	2,235	(11,817)	(2,222)
Less: Mandatory convertible preferred stock dividends accumulated during the period	345	58
Net earnings/(loss) attributable to Boeing common shareholders	1,890	(11,875)	(2,222)
Net earnings/(loss) attributable to Boeing common shareholders	$ 1,890	$ (11,875)	$ (2,222)
Basic earnings/(loss) per share (in dollars per share)	$ 2.49	$ (18.36)	$ (3.67)
Diluted earnings/(loss) per share (in dollars per share)	$ 2.48	$ (18.36)	$ (3.67)
Sales of products
Total revenues	$ 75,356	$ 53,227	$ 65,581
Cost of goods and services sold	(73,761)	(57,394)	(59,864)
Sales of services
Total revenues	14,107	13,290	12,213
Cost of goods and services sold	$ (11,413)	$ (11,114)	$ (10,206)

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows – operating activities:
Net earnings/(loss)	$ 2,238	$ (11,829)	$ (2,242)
Non-cash items –
Share-based plans expense	426	407	690
Treasury shares issued for 401(k) contribution	1,530	1,601	1,515
Depreciation and amortization	1,953	1,836	1,861
Investment/asset impairment charges, net	45	112	46
Gain on dispositions, net	(9,672)	(46)	(2)
777X and 767 reach-forward losses	5,283	4,079
Other charges and credits, net	264	528	3
Changes in assets and liabilities –
Accounts receivable	(95)	(37)	(128)
Unbilled receivables	(677)	(60)	321
Advances and progress billings	(723)	4,069	3,365
Inventories	(1,501)	(12,353)	(1,681)
Other current assets	155	(16)	389
Accounts payable	724	(793)	1,672
Accrued liabilities	1,341	1,563	779
Income taxes receivable, payable and deferred	115	(567)	44
Other long-term liabilities	(346)	(329)	(313)
Pension and other postretirement plans	(593)	(959)	(1,049)
Financing receivables and operating lease equipment, net	274	512	571
Other	324	202	119
Net cash provided/(used) by operating activities	1,065	(12,080)	5,960
Cash flows – investing activities:
Payments to acquire property, plant and equipment	(2,942)	(2,230)	(1,527)
Proceeds from disposals of property, plant and equipment	82	49	27
Acquisitions, net of cash acquired	(1,248)	(50)	(70)
Proceeds from dispositions	10,585	124
Contributions to investments	(51,938)	(13,856)	(16,448)
Proceeds from investments	46,628	4,743	15,739
Supplier notes receivable	(662)	(694)	(162)
Repayments on supplier notes receivable	2	40
Purchase of distribution rights	(9)	(88)
Other	1	(11)	4
Net cash provided/(used) by investing activities	499	(11,973)	(2,437)
Cash flows – financing activities:
New borrowings	165	10,161	75
Debt repayments	(3,621)	(8,673)	(5,216)
Common stock issuance, net of issuance costs		18,200
Mandatory convertible preferred stock issuance, net of issuance costs		5,657
Stock options exercised			45
Employee taxes on certain share-based payment arrangements	(34)	(83)	(408)
Dividends paid on Mandatory convertible preferred stock	(331)
Other	58	(53)	17
Net cash (used)/provided by financing activities	(3,763)	25,209	(5,487)
Effect of exchange rate changes on cash and cash equivalents	40	(47)	30
Net (decrease)/increase in cash & cash equivalents, including restricted	(2,159)	1,109	(1,934)
Cash & cash equivalents, including restricted, at beginning of year	13,822	12,713	14,647
Cash & cash equivalents, including restricted, at end of year	11,663	13,822	12,713
Less restricted cash & cash equivalents, included in Investments	742	21	22
Cash and cash equivalents at end of year	$ 10,921	$ 13,801	$ 12,691

Consolidated Statements of Financial Position - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents	$ 10,921	$ 13,801
Short-term and other investments	18,479	12,481
Accounts receivable, net	2,921	2,631
Unbilled receivables, net	9,158	8,363
Current portion of financing receivables, net		207
Inventories	84,679	87,550
Other current assets, net	2,301	2,965
Total current assets	128,459	127,998
Financing receivables and operating lease equipment, net	241	314
Property, plant and equipment, net	15,361	11,412
Goodwill	17,275	8,084
Acquired intangible assets, net	1,567	1,957
Deferred income taxes	107	185
Investments	1,048	999
Other assets, net of accumulated amortization of $1,014 and $1,085	4,177	5,414
Total assets	168,235	156,363
Liabilities and equity
Accounts payable	13,109	11,364
Accrued liabilities	27,141	24,103
Advances and progress billings	59,404	60,333
Short-term debt and current portion of long-term debt	8,461	1,278
Total current liabilities	108,115	97,078
Deferred income taxes	216	122
Accrued retiree health care	2,091	2,176
Accrued pension plan liability, net	4,287	5,997
Other long-term liabilities	2,432	2,318
Long-term debt	45,637	52,586
Total liabilities	162,778	160,277
Shareholders’ equity:
Common stock, par value $5.00 – 1,200,000,000 shares authorized; 1,012,261,159 shares issued	5,061	5,061
Additional paid-in capital	21,441	18,964
Treasury stock, at cost	(28,029)	(32,386)
Retained earnings	17,252	15,362
Accumulated other comprehensive loss	(10,277)	(10,915)
Total shareholders' equity/(deficit)	5,454	(3,908)
Noncontrolling interests	3	(6)
Total equity	5,457	(3,914)
Total liabilities and equity	168,235	156,363
Mandatory convertible preferred stock
Shareholders’ equity:
Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750	$ 6	$ 6